Financial statements Ipharm 1

Balance sheet of Ipharm 1

Company age:
Age:
12 y. 5 m. 23 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of IPHARM 1

Year
2019
2020
2021
2022
2023
Total assets 609 447,24 487 672,92 533 300,05 554 363,61 753 636,61
A. Fixed assets 55 839,26 44 352,02 32 864,78 21 377,54 76 561,57
B. Current assets 553 607,98 443 320,90 500 435,27 532 986,07 677 075,04
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 609 447,24 487 672,92 533 300,05 554 363,61 753 636,61
A. Equity 195 112,95 218 680,02 215 432,48 149 331,42 232 923,49
B. Liabilities and provisions for liabilities 414 334,29 268 992,90 317 867,57 405 032,19 520 713,12
I. Long-term liabilities - - - - -
II. Short-term liabilities - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.